Skip to main content
. 2002 Jun 5;86(11):1790–1796. doi: 10.1038/sj.bjc.6600323

Figure 1.

Figure 1

Progression-free survival (A) and post-relapse overall survival (B) as a function of hK10 status in advanced breast cancer patients treated with tamoxifen. Patients at risk are indicated. Cut point used for hK10, 86 ng mg−1 protein. RHR, relative hazards ratio. CI, confidence interval.